Nucléosides

<p>5-Ethynylpyrimidine is a supramolecular alkynyl group that has been shown to inhibit tyrosine kinase activity, cross-coupling, and the synthesis of proteins. It also exhibits luminescent properties and can be used in supramolecular chemistry. 5-Ethynylpyrimidine is a pyrimidine nucleoside, which is an organic compound that is a component of RNA. Pyrimidine nucleosides are important for protein synthesis and are used as luminophores or fluorescent resonance quenchers in biochemical assays for enzyme activity; they have also been shown to inhibit herpes simplex virus (HSV) replication. 5-Ethynylpyrimidine has been found to be able to bind terminal alkynes with high affinity.</p>

<p>AICAR 3',5'-cyclic phosphate is an antiviral and anticancer agent that inhibits the production of DNA and RNA, which may be due to its ability to activate AMP-activated protein kinase. AICAR 3',5'-cyclic phosphate has been shown to inhibit the proliferation of human breast cancer cells in vitro. This drug also has anticancer activity against various types of cancers, including prostate cancer and melanoma. AICAR 3',5'-cyclic phosphate is a novel compound that can be used as a phosphoramidite reagent for the synthesis of oligonucleotides.</p>

<p>2'-Methyl-guanosine-(iBu)-succinyl-CPG is a modified nucleoside with antiviral and anticancer properties. It is synthesized by the condensation of 2'-methyl-guanosine and succinic anhydride in the presence of tetrazole. The compound is a phosphoramidite, which is used as a building block for DNA synthesis.</p>

<p>4,5-Dimethoxy-2-nitrobenzyl adenosine 3',5'-cyclic monophosphate is a synthetic nucleotide that can be activated to form an antiviral and anticancer agent. This compound has been shown to inhibit the proliferation of leukemia cells in culture. It also inhibits the synthesis of DNA and RNA, leading to cell death by inhibiting the production of proteins vital for cell division. 4,5-Dimethoxy-2-nitrobenzyl adenosine 3',5'-cyclic monophosphate is a novel nucleoside with high purity and CAS number: 57314-27-1.</p>

<p>5'-O-Acetyl-2',3'-O-isopropylideneadenosine is an anti-leishmanial agent that is synthesized from 2,3-O-isopropylideneadenosine by acetylating the 5' hydroxyl group. It was found to be more potent than the parent compound and other related compounds in inhibiting Leishmania amazonensis promastigotes. The proposed mechanism of action of 5'-O-acetyl-2',3'-O-isopropylideneadenosine involves hydrogen bonding with the guanosine moiety of DNA and inhibition of RNA synthesis. This drug also has an effect on carbonyl oxygens and resonances, which are observed in the nmr spectra. The synthetic scheme for this drug starts with uridine, which is converted to cytidine by reacting it with sodium cyanide in aqueous solution at 0°C. Cytidine</p>

<p>2-Amino-benzoyl-9-(5'-O-DMT-b-D-ribofuranosyl)purine is an anticancer and antiviral agent. It has been shown to be active against many viruses, including herpes simplex virus type 1, herpes simplex virus type 2, cytomegalovirus, and human immunodeficiency virus type 1. This compound also exhibits antitumor activity in mice and rats.</p>

<p>5'-Deoxy-5'-iodo-2',3'-O-isopropylidene-5-chlorouridine is a novel antiviral agent that inhibits replication of viruses. It is synthesized from 5'-deoxy-5'-iodo-2',3'-O-isopropylideneuridine, which is then phosphorylated by the addition of a phosphate group. This compound has shown to be an activator in the synthesis of ribonucleosides and deoxyribonucleosides. The high purity and high quality of this compound make it suitable for use as a starting material for the synthesis of modified nucleosides for anticancer drugs.</p>

<p>N4-Acetyl-2'-deoxy-5'-O-DMT-cytidine 3'-Q linker CPG 1000Å is a nucleoside analog that is used in the synthesis of DNA. It is a phosphoramidite that has been modified with an acetyl group at the 2' position and a Q linker at the 3' position. This product can be used as an antiviral or anticancer agent, as well as for other research purposes. The CAS number for this product is 62660-67-7, and it has been shown to be active against HIV and HCV.</p>

<p>2',3'-Dideoxycytidine-5'-triphosphate lithium salt is a novel nucleoside, which can be used in the synthesis of oligonucleotides and DNA. The phosphoramidite is highly reactive and stable, and has been shown to have antiviral activity against influenza A virus. This chemical has also been shown to inhibit the growth of cancer cells by inhibiting DNA synthesis.</p>

<p>N2-O-Acetyl-2'-deoxy-3',5'-di-O-acetyl-O6-DPC-a-b-guanosine is a modified nucleoside that has antiviral and anticancer activities. It is synthesized by the modification of deoxyribonucleosides with acetyl groups at the 2' position, which are then removed using hydrolysis. The resulting product is a phosphoramidite intermediate that can be used in the synthesis of oligodeoxynucleotides. This compound has shown to have high quality and purity, as well as being novel.</p>

<p>2',3'-Di-O-isopropylidene-isocytidine is a nucleoside that belongs to the group of antiviral and anticancer compounds. It is an analog of cytidine, and has been shown to be an activator of phosphoramidites, DNA, and RNA. 2',3'-Di-O-isopropylidene-isocytidine has been shown to have antineoplastic effects on tumor cells by inhibiting rna synthesis and protein synthesis. This compound also inhibits the growth of bacteria, including Mycobacterium tuberculosis and Mycobacterium avium complex. 2',3'-Di-O-isopropylidene-isocytidine has been shown to be a novel modified nucleoside with high purity and high quality.</p>

<p>2’,3’,5’-Tri-O-benzoyl-5-methoxyuridine is a modified nucleoside that is structurally similar to the natural nucleoside uridine. It has antiviral properties and can be used as a monophosphate, diphosphate, or nucleotide. 2’,3’,5’-Tri-O-benzoyl-5-methoxyuridine is synthesized by reacting 5′-(triacetyl)aminoimidazole with 5′-(triisopropyl)phosphoroamidite in acetonitrile. The product has been shown to have anticancer activity in vitro and in vivo.</p>

<p>O6-Benzyl-8-bromo-3',5'-O(1,1,3,3-tetrakis(isopropyl)-1,3-disiloxanediyl)2'-deoxyguanine is a modified nucleoside that is used as an antiviral and anticancer agent. It has been shown to be a potent activator of the immune system. The monophosphate form of O6-benzyl-8-bromo-3',5'-O(1,1,3,3-tetrakis(isopropyl)-1,3-disiloxanediyl)2'-deoxyguanine may be useful in the treatment of viral diseases such as HIV or herpes zoster.</p>

<p>2'-Deoxy-5'-O-DMT-5-fluorouridine (2'DFUR) is a synthetic nucleoside that inhibits the synthesis of DNA. 2'DFUR is an antiviral and anticancer agent, which prevents viral replication by inhibiting the enzyme RNA polymerase and the synthesis of DNA. 2'DFUR has been shown to inhibit the proliferation of leukemia cells in vitro, as well as to inhibit tumor growth in vivo. The molecular weight of 2'DFUR is 284.23 g/mol, with a CAS number of 52488-02-9.</p>

<p>5’-O-DMT-N4-Phenoxyacetyl-2’-O-methylcytidine is an Activator and Anticancer agent. The synthesis of this product is based on the modification of cytidine to 2’,4,6,-trimethoxybenzoylcytidine. This product has been shown to be more potent than other cytidine analogs in inhibiting the growth of cancer cells. 5'-O-DMT-N4-Phenoxyacetyl-2'-O-methylcytidine is a novel nucleoside that has been shown to have antiviral activity against human immunodeficiency virus (HIV).</p>

<p>Adenosine 3',5'-diphosphate barium salt is a nucleoside that is used in the synthesis of oligonucleotides. Adenosine 3',5'-diphosphate barium salt is an excellent nucleoside for phosphoramidite chemistry and can be used to synthesize RNA, DNA, or modified nucleic acids. It has antiviral and anticancer activity. This compound has been shown to inhibit the growth of human tumor cells in culture by interfering with DNA synthesis.</p>

<p>2’,3’-Dideoxy-3’-chloro-5-methyl-5’-O-trityluridine (ddCTP) is a novel nucleoside analog that is synthesized by the protection of the 5'-hydroxyl group with an acetyl group followed by a 2',3'-dideoxy substitution. This compound has been shown to have antiviral and anticancer activities. ddCTP is an activator of DNA polymerase and inhibits viral DNA synthesis in vitro. It also inhibits protein synthesis and cell division by binding to the RNA template strand, which prevents it from being used as a template for protein synthesis.</p>

<p>5-O-DMT-thymidine 3'-H phosphonate triethylammonium is a novel nucleoside analogue with anticancer activity. The monophosphate form of 5-O-DMT-thymidine 3'-H phosphonate triethylammonium is an activator of DNA, RNA, and protein synthesis in vitro. 5-O-DMT-thymidine 3'-H phosphonate triethylammonium has been shown to be active against herpes simplex virus type 1 and 2 and HIV type 1 in vitro.</p>

<p>6-(4-Fluorophenyl)pyrimidine-2,4-diamine is an organic compound that has been shown to inhibit the proliferation of cells in vitro and to induce apoptosis. It also inhibits the growth of cancer cells. 6-(4-Fluorophenyl)pyrimidine-2,4-diamine mediates the activation of arylation, which is a chemical reaction that produces a new carbon-carbon bond between two or more molecules. This reaction is involved in the process of angiogenesis. In addition, this compound has been shown to be reactive with other compounds that are known to cause mutations and cellular damage.</p>

<p>8-Azidoadenosine 5'-triphosphate tetralithium salt is a modified nucleoside phosphoramidite. It can be used as an activator for the synthesis of both DNA and RNA oligonucleotides. 8-Azidoadenosine 5'-triphosphate tetralithium salt has antiviral activity, which may be due to its ability to inhibit viral protein synthesis by blocking the function of the virus's ribonuclease. This compound also has anticancer properties, which are likely due to its ability to inhibit DNA synthesis in tumor cells.</p>

<p>BiotinTEG Phosphoramidite is a medicinal compound that acts as an inhibitor of cancer cell growth. It has been shown to induce apoptosis in human tumor cells, making it a promising anticancer agent. This compound is an analog of Chinese hamster ovary (CHO) kinase inhibitors and has been found to inhibit the activity of various kinases involved in cancer cell proliferation. BiotinTEG Phosphoramidite is also used as a protein labeling agent due to its ability to attach biotin molecules to proteins, allowing for their detection and purification. This compound can be detected in urine, making it useful for monitoring drug levels during treatment. Overall, BiotinTEG Phosphoramidite holds great potential as a therapeutic agent for cancer treatment and protein labeling in research applications.</p>

<p>(2R,3R,4S,5R)-2-[6-Amino-2-(propylsulfanyl)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol is a novel nucleoside that has antiviral and anticancer properties. It is synthesized from deoxyribonucleosides and phosphoramidites by reacting with high purity acetic anhydride in the presence of triethylamine as catalyst. The compound is also known as (2R,3R,4S,5R)-2-[6-Amino-2-(propylsulfanyl)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol or 2'-deoxy[(2R,3R,4S,5R)-2-[6-(aminopropyls</p>

<p>5'-O-DMT-2'-O-pentylaminoadenosine is a phosphoramidite nucleoside monophosphate. It is a novel anticancer and antiviral agent that has been shown to kill cancer cells, inhibit viral replication, and inhibit the synthesis of DNA in the cell. 5'-O-DMT-2'-O-pentylaminoadenosine has been shown to be an effective inhibitor of herpes simplex virus type 1 (HSV1) replication in vitro. This drug also inhibits the synthesis of DNA and RNA by inhibiting nucleoside diphosphate kinase, which is a key enzyme in the metabolism of nucleosides.</p>

<p>2'-Deoxycytidine phosphoramidite dimer is a Novel, high quality, and CAS No. Phosphoramidites that are synthesized from deoxyribonucleosides and have antiviral, anticancer, and ribonucleoside activities. These compounds are monophosphate, which means they can be used for the synthesis of DNA or RNA. The 2'-Deoxycytidine phosphoramidite dimer is modified with a 2'-deoxycytidine moiety. This modification increases the stability of the compound in cells and increases its ability to inhibit the replication of viruses such as HIV-1.</p>

<p>3'-Deoxyadenosine CPG is a nucleoside that is synthetically manufactured. It is a monophosphate, which can be activated to a diphosphate by the enzyme phosphoramidase. 3'-Deoxyadenosine CPG has antiviral activity and is used in the treatment of Hepatitis B and C. It also has been shown to inhibit replication of DNA and RNA viruses such as HIV-1. 3'-Deoxyadenosine CPG binds to viral DNA or RNA by base pairing with the phosphate group on its 5' carbon atom, which prevents viral replication by preventing the polymerization of nucleic acids during transcription. This product is purified with an average purity of 99% and CAS number 120775-80-0.br&gt;br&gt;<br>3'-Deoxyadenosine CPG (3'-DAD) is a modified nucleoside that was synthesized for use in antiviral therapy against hepatitis B virus</p>

<p>This is a nucleotide analog that is used as a building block in DNA synthesis. It can be obtained from various sources, such as Sigma-Aldrich, Inc.</p>

<p>6-Chloro-2-iodo-9-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)purine is a protected purine nucleoside</p>

<p>3'-Azido-3'-deoxythymidine-methyl-D3-b-D-glucuronide sodium salt is a novel antiviral nucleoside phosphoramidite that has been shown to be an effective activator in the synthesis of diphosphate and triphosphate analogs. The novel antiviral nucleoside phosphoramidite was synthesized from 3'-azido-3'-deoxythymidine, methyl bromoacetate and sodium hydroxide in methanol at room temperature. It is structurally similar to the natural nucleosides, deoxyribonucleosides and ribonucleosides with modifications on the sugar moiety and phosphate group. This compound is a high quality synthetic material for use in pharmaceutical research, as an anticancer agent and as a potential antiviral drug.</p>

<p>5-Bromo-2-methylsulfanyl-pyrimidine-4-carboxylic acid is a pyrimidine derivative that inhibits protein kinases. The compound has been shown to inhibit the activity of protein kinase C, which is involved in mediating inflammatory responses, and phosphorylation of the insulin receptor substrate 1. 5-Bromo-2-methylsulfanyl-pyrimidine-4-carboxylic acid is an efficient inhibitor of kinases and can be used as a lead compound for the development of new compounds with therapeutic potential.</p>

<p>5'-O-Acetyl-3'-azido-2',3'-dideoxy-N2-palmitoylguanosine is a novel antiviral and anticancer agent. It is an analogue of the natural nucleoside guanosine. It has been modified with an acetyl group at the 5' position of the pentose moiety and an azido group at the 2' and 3' positions of the ribose moiety. The acetyl group makes this compound more water soluble, which means it can be easily administered intravenously for treatment of cancer or infection.</p>

<p>1-(2-Deoxy-b-D-ribofuranosyl)-4-methylindole is a nucleoside that can be used as an activator for phosphoramidite synthesis. It is also known to have antiviral, anticancer, and antimalarial properties. 1-(2-Deoxy-b-D-ribofuranosyl)-4-methylindole has been shown to inhibit the proliferation of human leukemia cells in culture. It has also been shown to suppress HIV replication in vitro by inhibiting viral RNA synthesis.</p>

<p>2-Amino-4-(4-fluorophenyl)pyrimidine is a fluorinated derivative of imatinib, which is a chemical that inhibits the activity of tyrosine kinases. It has been shown to be a more potent inhibitor than imatinib, and it also offers high yields and regioselectivity. This compound can be used in organic chemistry to produce fluorinated derivatives.</p>

<p>2'-Amino-2'-deoxyguanosine-5'-triphosphate tetralithium salt is a novel nucleoside analog that has antiviral and anticancer activities. It is a high quality, modified nucleoside that can be used for the synthesis of deoxyribonucleosides or ribonucleosides. It is synthesized from 2'-amino-2'-deoxyguanosine triphosphate and a lithium salt of tetrabutylammonium. This product has a CAS number of 108269-13-2 and a purity level of ≥99%.</p>

<p>3'-Deoxy-2-fluoroadenosine is a byproduct of the metabolism of nucleoside phosphorylase. It can be used as a chromatographic agent for the separation of nucleic acids and proteins. 3'-Deoxy-2-fluoroadenosine can also be used in the preparation of immunofluorescence and immunohistochemical staining. 3'-Deoxy-2-fluoroadenosine is found in tissues that are rich in neurofilaments, such as brain tissue, and is often used to stain these tissues for histological examination. Cancer cells have been shown to produce 3'-deoxy-2-fluoroadenosine at a higher rate than normal cells, so it can also be used as an indicator of cancer. The thermophilic bacterium Thermus thermophilus produces high levels of this compound during DNA replication, which may be due to its role in the synthesis of d-arabinose from rib</p>

<p>2'-C-Ethynylcytidine is a synthetic surfactant that can be used in coatings and other surface treatments. It has been shown to inhibit the growth of bacteria and viruses, as well as being effective against a variety of bacterial species. 2'-C-Ethynylcytidine binds to sulfide, which is produced by bacteria, leading to cell death. The antimicrobial activity of 2'-C-Ethynylcytidine is due to its ability to form ester linkages with polyesters, which are able to penetrate the bacterial cell membrane and disrupt the integrity of the cytoplasmic membrane. This leads to leakage of intracellular contents, followed by cell death. 2'-C-Ethynylcytidine also has been shown to bind to metal ions such as silver, copper, zinc and cadmium and prevent their uptake into cells.</p>

<p>2-(2-Methylphenyl)pyrimidine-5-carbaldehyde is a crystalline solid that has been shown to have synergistic effects with polypropylene. It is synthesized from 2-methylphenylacetonitrile and 2,4-dichloro-6-(trifluoromethyl)pyrimidine in the presence of sodium metal. The product is soluble in alcohols and ethers, but insoluble in water.</p>

<p>5’-O-DMT-thymidine 3’-Me phosphoramidite is a novel and modified nucleotide analog that is used as an antiviral agent. It has been shown to be active against herpes simplex virus type 1 (HSV-1) and Epstein-Barr virus (EBV). 5'-O-DMT-thymidine 3’-Me phosphoramidite is not active against HIV, although it has been shown to inhibit the replication of Hepatitis B virus. This compound can also be used in cancer therapy.<br>5'-O-DMT-thymidine 3' -Me phosphoramidite inhibits cellular DNA synthesis by competing with natural thymidine monophosphate (TMP) for incorporation into DNA. The incorporation of 5'-O-DMT-thymidine 3' -Me into DNA leads to a high frequency of mutations, which causes the death of the cell.</p>

<p>2'-Deoxy-5'-O-DMT-5-fluoro-4-O-(2,4,6-trimethylphenyl)uridine 3'-CE-phosphoramidite is a novel phosphoramidite monophosphate. It is modified to include fluorine at the 5 position of the uridine moiety and has antiviral activity. This product is a nucleoside with antiviral properties that can be used in cancer treatments. 2'-Deoxy-5'-O-DMT-5-fluoro-4-O-(2,4,6-trimethylphenyl)uridine 3'-CE phosphoramidite is synthesized from deoxyribonucleosides and ribonucleosides by using a high purity process.</p>

<p>Building block for the introduction of uridine units into oligonucleotides</p>

<p>NPE-caged- GTP sodium salt is a novel nucleoside that can be used as a monophosphate or ribonucleotide, which is synthesized through the use of chemical phosphoramidites. NPE-caged- GTP sodium salt has been shown to have anticancer and antiviral properties in vitro. The synthesis of this compound is a novel modification of GTP, which makes it an activator for specific DNA sequences. It also has high purity and high quality.</p>

<p>Abacavir carboxylate is a prodrug of abacavir that is activated by the carboxylation of the terminal hydroxyl group in the liver. It has been shown to be quantified using a liquid chromatography-mass spectrometry (LC-MS) method. Abacavir carboxylate has an additional benefit of being less sensitive to degradation by nitrate, which can interfere with the analysis of acyclovir. The deuterium label on abacavir carboxylate ensures that it is not confused with acyclovir and facilitates identification in wastewater samples.</p>

<p>2'-Deoxy-2'-fluoroguanosine-5'-triphosphate lithium salt - 100mM aqueous solution is an antiviral agent of the deoxyribonucleoside family. It is a novel antiviral agent that inhibits viral replication by inhibiting viral DNA synthesis, and it also has anticancer activities. 2'-Deoxy-2'-fluoroguanosine-5'-triphosphate lithium salt - 100mM aqueous solution is modified from guanosine monophosphate (GMP), which is a nucleotide precursor in DNA synthesis, and can be used as an activator for phosphoramidites in the synthesis of DNA.</p>

<p>N6-Benzoyl-7'-OH-morpholino adenosine is a modified nucleoside with antiviral activity. It is being developed as an activator of ribonucleotide reductase and a potential anticancer agent. N6-Benzoyl-7'-OH-morpholino adenosine is synthesized by reacting benzoyl chloride with 7'-O-dimethoxytritylmorpholine. This reaction results in the formation of the desired product, which has been shown to be an activator of ribonucleotide reductase. The synthesis of this compound can be performed on a large scale, making it an attractive candidate for chemotherapeutic use.</p>

<p>2'-O-tert-Butyldimethylsilyluridine is a nucleoside that is used in DNA synthesis, antiviral research, and anticancer therapy. It is synthesized from 2'-deoxyuridine monophosphate (2'-dUMP) with the aid of a phosphoramidite coupling agent. It has shown to be an effective activator in the synthesis of oligonucleotides, which are short chains of nucleotide units that can be used for various purposes including the treatment of cancer cells. These chains are synthesized by linking together individual nucleosides with phosphate molecules at each end. The bonds between these phosphate groups and the sugar-phosphate backbone of the nucleotide units are called phosphodiester bonds. This synthetic process can be used to produce DNA or RNA strands as well as modified versions of these strands such as those that have been synthesized with other chemical groups on their sugar-phosphate backbones.</p>

<p>5'-O-DMT-2'-O-propynyluridine 3'-CE phosphoramidite is a novel nucleoside analogue that can be used to synthesize DNA and RNA. This compound has antiviral and anticancer properties, which may be due to its ability to inhibit the synthesis of RNA. This product is also high quality, high purity, and low cost. 5'-O-DMT-2'-O-propynyluridine 3'-CE phosphoramidite is an excellent chemical intermediate for the synthesis of nucleosides with modified sugar moieties. It can be used in pharmaceuticals and other chemical industries.</p>

<p>2'-Deoxy-2'-fluoro-2-hydroxy-b-D-arabinoadenosine is a novel nucleoside that was synthesized as a potential antiviral agent. It is an analog of adenosine and has been shown to inhibit the replication of HIV in vitro. This nucleoside is synthesized using a modified phosphoramidite approach and can be used in the synthesis of DNA or RNA. 2'-Deoxy-2'-fluoro-2-hydroxy-b-D-arabinoadenosine has also been shown to have anticancer activity.</p>

<p>2'-Deoxy-5'-O-DMT-N6-methyl-8-oxoadenosine 3'-CE phosphoramidite is a nucleotide analog that is used for the treatment of cancer. It inhibits sugar transport, which leads to tumor cell lysis. 2'-Deoxy-5'-O-DMT-N6-methyl-8-oxoadenosine 3'-CE phosphoramidite binds to glut1 and toll-like receptor 4 in the cell membrane, inhibiting the activation of these cells. This drug has been shown to have an antibody response in myeloma cells and basic fibroblast cell lines.</p>

<p>2'-Deoxy-5'-O-DMT-2'-fluoro-N2-isobutyrylguanosine 3'-O-succinate triethylammonium salt is a novel phosphoramidite that can be used as an activator for DNA synthesis. It is activated by the addition of an appropriate nucleophile and has been shown to be effective in antiviral and anticancer activities. This compound is synthesized through a modified diphosphate method and it is available in high purity with a CAS number.</p>

<p>2',3'-Dideoxy-3'-fluorocytidine is a synthetic nucleoside analog that inhibits DNA synthesis by blocking the incorporation of deoxycytidine into DNA. It is used to treat lymphocytic leukemia, hepatitis, and virus infections. 2',3'-Dideoxy-3'-fluorocytidine has been shown to inhibit cell growth in solid tumours. The drug has also been shown to inhibit the production of immunodeficiency viruses such as human immunodeficiency virus type 1 (HIV-1) and human T-lymphotropic virus type I (HTLV-I), which causes acquired immune deficiency syndrome (AIDS). 2',3'-Dideoxy-3'-fluorocytidine inhibits viral replication by inhibiting the activity of the enzyme deaminase, which converts dATP to dTTP. This prevents DNA replication and transcription.</p>

<p>Valopicitabine is a prodrug that is converted to its active form, 3'-deoxy-3'-methylvalopicitabine, in the body. Valopicitabine inhibits viral replication by a mechanism that is not yet fully understood. It has been shown to inhibit NS3 protease and induce an interferon response. Valopicitabine has also been shown to inhibit Toll-like receptor 4 (TLR4) activity and elicit an antiviral response. Valopicitabine has low bioavailability, which may be due to its high lipophilicity.</p>

<p>3'-O-Methyl-5'-guanylic acid is a novel antiviral, synthetic deoxyribonucleoside which is activated by phosphoramidites to produce 3'-O-methyl-5'-guanylic acid phosphoramidite. It has high purity and quality and can be used as a nucleoside activator for DNA synthesis. 3'-O-Methyl-5'-guanylic acid has been shown to be an anticancer agent that inhibits the growth of cancer cells in vitro by inhibiting DNA synthesis and cell division. This drug also has a potential use as an antiviral agent.</p>

<p>3'-Deoxyguanosine-5'-triphosphate lithium salt - 100mM aqueous solution is Novel and Antiviral. 3'-Deoxyguanosine-5'-triphosphate lithium salt - 100mM aqueous solution is Synthetic and Deoxyribonucleosides. 3'-Deoxyguanosine-5'-triphosphate lithium salt - 100mM aqueous solution is High quality and Ribonuclesides. 3'-Deoxyguanosine-5'-triphosphate lithium salt - 100mM aqueous solution has CAS No. 51445-81-9, Activator, Phosphoramidites, Modified and Anticancer.</p>

<p>Inosine 2',3'-cyclic monophosphate sodium salt (ICMP) is a phosphodiesterase inhibitor that inhibits the activity of protein kinases and phosphatases. ICMP is used in biochemical studies to inhibit tryptophan metabolism and protein synthesis. It also has been shown to be useful in the study of sequences, such as those found in DNA and RNA. ICMP has been shown to increase the mRNA levels of a number of proteins at lower concentrations than other inhibitors, making it a valuable tool for studying protein synthesis. The enzyme-inhibiting properties of ICMP have been observed in calf thymus DNA and bacterial DNA gyrase, dna topoisomerase, and rna synthesis. ICMP also inhibits caenorhabditis elegans phosphatases and can be used in genetic engineering experiments involving Xenopus oocytes.</p>

<p>3,7-Dihydro-5-iodo-4-oxo-4H-pyrrolo[2,3-d]pyrimidine is a novel antiviral drug with anticancer activity. It is an inhibitor of the enzyme ribonucleotide reductase and has been shown to inhibit the production of deoxyribonucleosides in tumor cells. It also inhibits DNA synthesis by inhibiting DNA polymerase. 3,7-Dihydro-5-iodo-4-oxo-4H-pyrrolo[2,3-d]pyrimidine is a high purity product that is available in both monophosphate and diphosphate forms.</p>

<p>7,8-Dihydro-8-thioxo-adenosine is a synthetic nucleoside that activates the synthesis of DNA and RNA by acting as a ribonucleotide. It also has antiviral and anticancer activities. 7,8-Dihydro-8-thioxo-adenosine is an antiviral agent against herpesviruses and retroviruses. The antitumor activity of this compound is due to its ability to inhibit the proliferation of tumor cells by inhibiting DNA synthesis. 7,8-Dihydro-8-thioxo-adenosine can be used in the treatment of leukemia and other cancers that are sensitive to cytotoxic drugs. This drug has been shown to have low toxicity in rats.</p>

<p>7-Benzyl-4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyriMidine is an antiviral agent that is a modified nucleoside. It has shown to be a novel activator of the immune system. 7BICP has been shown to have high antiviral activity against herpes simplex virus type 1 (HSV1) and type 2 (HSV2) in cell cultures. It also inhibits the replication of HIV and influenza A virus in cell cultures. This drug is synthesized from deoxyribonucleosides, phosphoramidites, or nucleosides. 7BICP is a monophosphate and diphosphate, which are used as substrates for DNA synthesis by DNA polymerase. The CAS number for 7BICP is 1244855-59-1.</p>

<p>2-Methyl-cytidine-(Bz)-succinyl-CPG; 500 Å (RNA) is a nucleoside analog that is modified with a 2'-methyl group. It is synthesized by the phosphoramidite method, which is performed in a high purity and high quality environment. This product can be used as an activator for DNA synthesis and has been shown to have anti-cancer and antiviral properties.</p>

<p>3,5-Di-O-toluoyl 6-chloropurine-7-b-D-deoxyriboside is a modified monophosphate nucleotide with antiviral and anticancer activity. It has been shown to be a potent activator of the enzyme DNA polymerase in vitro. This drug is synthesized by reacting 3,5-di-O-toluoyl 6-chloropurine with boron trichloride at high temperature. The final product was purified by HPLC and characterized using mass spectrometry. The purity of this compound is &gt;99% as determined by HPLC analysis.</p>

<p>5'-O-DMT-2'-ethylfluoro-5-methyluridine 3'-CE phophoramidite is an antiviral agent that has been shown to inhibit the replication of HIV in cell culture and to prevent the synthesis of the virus. 5'-O-DMT-2'-ethylfluoro-5-methyluridine 3'-CE phophoramidite inhibits viral replication by acting as a competitive inhibitor of HIV reverse transcriptase and blocking viral DNA synthesis from viral RNA. It has also been shown to have anticancer properties, which may be due to its ability to suppress tumor growth through inhibition of protein synthesis.</p>

<p>2'-Azido-2'-deoxyguanosine is an analog of guanine that is used as a fluorescent probe in biochemical and chemical biology studies. It can be synthesized using the azide method, which involves coupling an azide functional group to an aromatic ring. 2'-Azido-2'-deoxyguanosine can also be modified by a number of modifications, including attachment of fluorescent molecules or biotin for labeling purposes. The chemical structure of this compound has been shown to have a conformation that is similar to that of natural guanosine and uridine. 2'-Azido-2'-deoxyguanosine can be detected by proton nuclear magnetic resonance spectroscopy at about 3 ppm, which corresponds to its chemical shift in the range of 200–300 Hz. This compound also has biochemical properties that are similar to those observed for natural guanine and uridine.</p>

<p>Adenosine 2',3'-cyclic monophosphate-5'-monophosphate (AMP-CP) is a nucleotide that is the cyclic form of adenosine monophosphate. It is a modified nucleoside that is used in the synthesis of DNA and RNA, as well as in anticancer and antiviral research. The structure of AMP-CP consists of an adenosine base attached to ribose through a phosphate group at the 3' carbon position. This nucleotide can be converted to adenosine 5'-monophosphate (AMP) by phosphoramidites, which are chemical compounds consisting of an aminopropyl group joined to a phosphoryl group. AMP-CP is also known as diphosphate or deoxyribonucleosides.<br>AMP-CP has shown antiviral activity against herpes simplex virus type 1, HIV, influenza A virus, and vesicular stom</p>

<p>5-Iodo-2’-O-methylcytidine is a nucleoside that is used as an activator for the synthesis of ribonucleosides. It is also used in the synthesis of DNA, RNA, and phosphoramidites. 5-Iodo-2’-O-methylcytidine has shown anticancer activity against a variety of cancer cell lines. This novel nucleotide exhibits high quality and purity, with an excellent yield and low impurities. The compound has been assigned CAS No. 847650-69-5 and its physical properties have been described in detail.</p>

<p>Adenosine-5'-[-(propargyl)]triphosphate sodium salt is a modified nucleoside with anticancer activity. It has been shown to be a potent activator of DNA synthesis and an inhibitor of viral replication. Adenosine-5'-[-(propargyl)]triphosphate sodium salt is not active against bacterial cells, but it can be used in the treatment of cancer. This drug also has antiviral effects, which may be due to its ability to inhibit viral replication by binding to viral RNA polymerases or by inhibiting the transcriptional activation of genes encoding for enzymes that are required for mRNA synthesis.</p>

<p>2',3'-Dideoxyadenosine-5'-triphosphate lithium salt is a novel antiviral nucleoside that has the potential to be used in the treatment of various viral infections. It is synthesized from 2',3'-dideoxyadenosine monophosphate and lithium salt, and has been shown to have high antiviral activity against DNA viruses such as herpes simplex virus and adenovirus. It also inhibits the replication of RNA viruses such as influenza A virus, vesicular stomatitis virus, and measles virus. 2',3'-Dideoxyadenosine-5'-triphosphate lithium salt is a modified nucleoside that is phosphoramidite activated with a group at the 2' position on the ribose sugar. The phosphate group can be removed by hydrolysis or enzymatic catalysis, which leaves behind an unsaturated sugar moiety. This leads to an increased rate of incorporation into</p>

<p>N-Acetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)adenosine is a novel nucleoside analog which has been modified to improve its anticancer activity. This compound is an activator of adenosine deaminase and inhibits the proliferation of various tumor cells. It also blocks the formation of DNA by inhibiting the synthesis of ribonucleotides. N-acetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)adenosine has antiviral properties and can inhibit HIV replication in vitro.</p>

<p>4-(1-Benzylpiperidin-4-Ylamino)-2-(Methylthio)Pyrimidine-5-Carboxylic Acid is a novel nucleoside analog that has been shown to have anticancer activity. It has also been found to have antiviral and antitumor activities. 4-(1-Benzylpiperidin-4-Ylamino)-2-(Methylthio)Pyrimidine-5-Carboxylic Acid is a nucleoside analog that is synthesized from monophosphate, diphosphate, and phosphate esters of 2-(methylthio)pyrimidine 5'-carboxylic acid. It is an analogue of the natural nucleoside uridine and has phosphorylase enzyme activity. This agent is cytotoxic against cells in culture by inhibiting DNA synthesis.</p>

<p>2'-Deoxy-N2-isopropylguanosine is a nucleoside that is synthesized from 2'-deoxy-N6-methyladenosine and isopropyl alcohol. It has antiviral and anticancer properties. The antiproliferative effects of this drug are mediated by the inhibition of DNA synthesis in cells. This compound also inhibits the activation of the transcriptional factor NF-κB, which regulates inflammatory responses in the body.</p>

<p>1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole is a nitrofuranose analog that is used in the synthesis of nucleic acids. It has been shown to be effective as a template for DNA sequencing and as a probe for magnetic resonance spectroscopy. 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole inhibits the polymerase chain reaction by binding to the primer and causing misincorporation at mismatched sites, leading to reduced amplification of the target sequence. This compound also has antiviral properties and can prevent the replication of HIV and other viruses by destabilizing their dna duplexes.</p>

<p>9-(b-D-arabinofuranosyl)-N6-benzoyladenine is a novel nucleoside analogue that has been shown to be an effective anticancer agent. It is structurally related to the natural nucleosides adenosine and guanosine, but with the addition of a benzoyl group on the 9 position. This compound is also active against HIV, influenza A virus and herpes simplex virus type 1 (HSV1). It can be used as an antiviral agent in cancer therapy due to its ability to inhibit viral replication. 9-(b-D-arabinofuranosyl)-N6-benzoyladenine inhibits the growth of tumor cells by inhibiting DNA synthesis and RNA transcription. It also binds to DNA, thereby preventing DNA synthesis and RNA transcription.</p>

<p>2,2'-Anhydro-5'-O-t-butyldiphenylsilyluridine (2,2'-ABSU) is a novel modified nucleoside that was synthesized in order to be used as an antiviral agent. 2,2'-ABSU has shown to be an effective inhibitor of HIV-1 replication and it has been shown to have anticancer properties. This drug is high quality and can be used for the manufacture of phosphoramidites.</p>

<p>3'-Azido-3'-deoxythymidine methyl-D3 is a novel synthetic nucleoside. It is a modified version of the natural nucleoside deoxyribonucleoside, which is an essential component of DNA and RNA. 3'-Azido-3'-deoxythymidine methyl-D3 is an activator of the antiviral and anticancer properties of other drugs. It can be used as a phosphate donor in phosphoramidite synthesis to produce oligonucleotides for use in PCR amplification or in protein synthesis. 3'-Azido-3'-deoxythymidine methyl-D3 is also used as an antiviral agent because it inhibits viral replication by inhibiting viral reverse transcriptase.</p>

<p>3'-O-Acetyl-5-benzylaminocarbonyl-2'-O-methyl-5'-O-DMT-uridine is a novel, modified nucleoside. This product is an activator of the ribonucleotide reductase enzyme and is used as a precursor in the synthesis of deoxyribonucleosides. It has antiviral activity against herpes simplex virus type 1 and cytomegalovirus. It has also been shown to have anticancer properties, as it inhibits DNA synthesis and tumor cell proliferation without affecting healthy cells. 3'-O-Acetyl-5-benzylaminocarbonyl-2'-O-methyl-5'-O-DMT uridine is synthesized from 5-(3,4,5)-trimethoxybenzaldehyde, 2′(2,6 dichloro)amino]methyl]benzeneacetic acid methyl ester and 5</p>

<p>2'-Ethylfluoro-5'-O-DMT-5-methylcytidine is a novel antiviral agent that is synthesized from 2'-deoxyribonucleosides. This product has been shown to be an effective activator of the human immune system and has potent anticancer activity. It inhibits DNA synthesis and protein synthesis, which leads to the death of cancer cells. In addition, this product has a high purity and high quality.</p>

<p>N6-2-(4-Aminophenyl)ethyladenosine is a carbamazepine prodrug that is converted to the active form, carbamazepine, by esterases. It has been shown to inhibit the binding of adenosine to adenosine receptor subtypes and to have an antagonistic effect on the activity of endogenous adenosine at these receptors. N6-2-(4-Aminophenyl)ethyladenosine has also been shown to act as an antagonist at the A3 adenosine receptor. This drug has been shown to reduce bronchoconstrictor responses in animal models and may be used for treating asthma.<br>N6-2-(4-Aminophenyl)ethyladenosine has also been shown in vitro studies using human papillary muscle cells to enhance polymerase chain reactions (PCR).</p>

<p>N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine 3'-CE phosphoramidite is an antiviral agent that inhibits the activity of viral DNA polymerase. This chemical has been shown to be effective against herpes virus, pox virus and HIV. N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine 3'-CE phosphoramidite is a novel nucleotide analogue that contains a modified deoxyribose sugar backbone. It has been shown to be active against cancer cells in vitro, but not in vivo.</p>

<p>Please enquire for more information about 2′-O-Succinyladenosine 3′,5′-monophosphate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>2'-Deoxy-6N-DMF-5'-O-DMT-adenosine is a novel antiviral agent that is activated by phosphoramidites and has high quality, high purity, and good stability. It has been shown to inhibit the replication of DNA by binding to the 3' hydroxyl group of deoxyribonucleotides. 2'-Deoxy-6N-DMF-5'-O-DMT-adenosine also inhibits the synthesis of RNA by binding to nucleoside monophosphates. This compound is synthesized in a modified form as an analog of adenosine and has been shown to be active against herpes simplex virus type 1 (HSV1).</p>

<p>8-Bromo-2'-deoxy-N2-DMF-5'-O-DMT guanosine 3'-CE phosphoramidite is a novel synthetic phosphoramidite and activator for the synthesis of oligodeoxynucleotides. The product is a white to off-white powder with a purity of 99% and an average molecular weight of 635.8. It has been used in the synthesis of oligonucleotides as an activator and monophosphate, including DNA, RNA, and PNA (peptide nucleic acid). 8-Bromo-2'-deoxy-N2-DMF 5'-O DMT guanosine 3'-CE phosphoramidite may be used as an anticancer drug or antiviral agent.</p>

<p>8-Aza-2'-deoxyadenosine is an anion that is cytotoxic to cells and can be activated to form a phosphate ester. It has been shown to have a higher cytotoxicity than adenosine in cell cultures, but is less effective in animal studies. 8-Aza-2'-deoxyadenosine has been shown to have a significant toxicity in rats and mice when administered at doses greater than 500 mg/kg body weight. The activation of 8-aza-2'-deoxyadenosine into the phosphate ester can be stereoselective. This activation has also been shown to cause enhancement of tumor growth inhibition.</p>

<p>2',3'-Di-O-acetyl-5'-O-DMT-5-methyluridine is a monophosphate nucleotide, which is an antiviral agent. It is a novel, high quality and high purity compound. The CAS number for 2',3'-Di-O-acetyl-5'-O-DMT-5-methyluridine is 69681-06-8. It has antiviral activity against the herpes simplex virus type 1 (HSV1) and Epstein Barr virus (EBV). This drug also inhibits DNA synthesis by inhibiting the enzyme DNA polymerase. This product can be used in research to synthesize phosphoramidites, activator molecules, and nucleosides.</p>

<p>2'-O-(2-Ethoxy-2-oxoethyl)adenosine is a nucleoside that is a modified version of adenosine. It is phosphorylated to form 2'-O-(2-ethoxy-2-oxoethyl)adenosin-5'-yl monophosphate, which has antiviral activity and is used as an antiviral agent in the treatment of herpes simplex virus. The chemical structure of this nucleoside is novel, and it binds to the ribonucleotide reductase enzyme to prevent the synthesis of DNA and RNA. This drug also has anticancer properties, but it is not active against bacterial infections.</p>

<p>cyclic guanosine monophosphate (cGMP) is increasingly recognized as having widespread consequences for human health which include regulation of biofilm formation as well as virulence.  It has now been identified as a specific and high affinity ligand for the GEMM class of bacterial riboswitches that regulate gene expression.</p>

<p>5,6-Dihydro-2'-deoxy-5'-O-DMT-uridine 3'-CE phosphoramidite is a modified nucleoside that is used as an activator in DNA synthesis. It has been shown to have anticancer properties by inhibiting the growth of cancer cells. 5,6-Dihydro-2'-deoxy-5'-O-DMT-uridine 3'-CE phosphoramidite is synthesized from the monophosphate form and can be used for the synthesis of both DNA and RNA.</p>

<p>2'-O-tert-Butyldimethylsilyl-N2-isobutyrylguanosine is an antiviral nucleoside that has been shown to inhibit the activity of a novel human DNA polymerase. This nucleoside is a monophosphate, CAS No. 182007-86-9, and is highly reactive with various phosphoramidites. 2'-O-tert-Butyldimethylsilyl-N2-isobutyrylguanosine is synthesized by the reaction of guanosine with dimethylchlorosilane in the presence of triethylamine. It can be used as a building block for synthesis of oligodeoxyribonucleotides or modified ribonucleotides.</p>

<p>Please enquire for more information about 5'-ODMT cEt G Phosphoramidite including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>6-Iodo-uridine is an antiviral drug that is used to treat tuberculosis, influenza, and hepatitis. It has a propionyl group in place of the hydroxyl group on the pyrimidine ring. This substitution stabilizes the molecule and prevents it from being broken down by enzymes in the body. 6-Iodo-uridine can be synthesized from uridine through a cross-coupling reaction with formaldehyde and propionaldehyde. 6-Iodo-uridine can also be synthesized by coupling orotic acid 5′ monophosphate decarboxylase with formaldehyde.</p>

<p>2’,3’,5’-Tri-O-(tert-butyldimethylsilyl)-adenosine is a novel nucleoside that is synthetically modified by the replacement of the ribose sugar with an amino sugar. The modification of the sugar reduces the likelihood of hydrolysis to ribose and phosphate. This product has shown anticancer effects against human tumor cells in vitro and in vivo. It also has antiviral activities against herpes simplex virus type 1 (HSV-1). 2’,3’,5’-Tri-O-(tert-butyldimethylsilyl)-adenosine is a monophosphate nucleoside that inhibits DNA synthesis by inhibiting DNA polymerase. It acts as a competitive inhibitor for deoxyribonucleotides and phosphoramidites, which are used in DNA synthesis. 2’,3’,5’-</p>

<p>N4-Benzoyl-2'-deoxy-5'-O-DMT-3'-O-(methanesulfonyl)cytidine is a novel nucleoside with anticancer and antiviral activities. It is synthesized by reacting 4-benzoyl cytidine with 2'-deoxy-5'-O-DMT, followed by the treatment with methanesulfonyl chloride. This compound can be used as an activator of DNA polymerase. It has also been shown to be effective against HIV in vitro.</p>

<p>N4-Benzoyl-3'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine 2'-CE phosphoramidite is a monophosphate nucleotide analog that inhibits the growth of cancer cells by binding to DNA and inhibiting the synthesis of RNA. This drug is a novel, modified nucleoside with anticancer properties. It binds to DNA and inhibits the synthesis of RNA, which may be due to its ability to inhibit the enzyme ribonucleotide reductase. N4-Benzoyl-3'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine 2'-CE phosphoramidite also has antiviral activity against HIV and Herpes Simplex Virus Type 1 (HSV1).</p>

<p>2'-O-tert-Butyldimethylsilyl-N6-chloroacetyl-N1-methyl-5'-O-MMT-adenosine 3'-CE phosphoramidite is an activated monophosphate chemical compound. It is a modified nucleoside that has been used for the synthesis of oligonucleotides and DNA. It also has anticancer, antiviral, and other pharmacological activities.</p>

<p>Emission max - 415nmMolar extinction coefficient ε [L·mol⁻¹·cm⁻¹] - 6000Fluorescent analogue of 5'-ADP, NA10698</p>

<p>2',5'-Bis-O-(triphenylmethyl)uridine is a synthetic nucleoside that is used in the treatment of leukemia. It is used as an analogue of uridine and guanosine, and is converted to these compounds by decarboxylase enzymes. 2',5'-Bis-O-(triphenylmethyl)uridine has been shown to inhibit the proliferation of L1210 cells in vitro and in vivo, but not normal cells. 2',5'-Bis-O-(triphenylmethyl)uridine also inhibits DNA synthesis by inhibiting the enzyme hydroxylase and carboxylate, which are involved in purine metabolism. This drug binds to the ribonucleotide reductase enzyme and blocks its activity, thereby inhibiting RNA synthesis.</p>

<p>This is a phosphoramidite that is used in the synthesis of DNA. The chemical name for this compound is 5'-O-DMT-N2-(4-isopropylphenoxyacetyl)-2'-O-methylguanosine 3'-CE phosphoramidite. This compound has been shown to be an anticancer drug and has high purity, high quality, and novel properties.</p>

<p>2-Methylsulfanyl-4-phenylpyrimidine is a heterocyclic compound that has been shown to be an effective anti-malarial agent. The drug inhibits the growth of malaria parasites by binding to the parasite's DNA and preventing its replication. 2-Methylsulfanyl-4-phenylpyrimidine also recycles the monocyclic pyrimidines, which are nucleophiles, and therefore can be used as a precursor for other drugs.<br>2-Methylsulfanyl-4-phenylpyrimidine is not very soluble in water but is soluble in organic solvents such as ethanol, propylene glycol, or acetone. It has also been found to form stable salts with perchlorate and guanidine.</p>

<p>Cytidine-5'-triphosphate is a nucleotide that is involved in the biosynthesis of fatty acids. It is synthesized by the enzyme cytidine triphosphate synthetase and converted to cytidine diphosphate (CDP) by the enzyme CTP synthetase. The nitrogen atoms are derived from ammonia. Cytidine-5'-triphosphate is found in mitochondria, where it participates in lipid synthesis. Cytidine-5'-triphosphate may also be used to treat cancer. This drug has been shown to inhibit tumor growth and metastasis, as well as induce apoptosis in cancer cells.</p>

<p>N4-p-Anisoylcytidine is a labile, crystalline, and water soluble oligoribonucleotide. It is an intermediate in the synthesis of cytidine and phenyl ring. N4-p-Anisoylcytidine can be prepared by reacting p-anisic acid with 4-benzoylcytosine. The reaction yields a mixture of products that can be purified by recrystallization or chromatography. It is hydrolyzed by acidic conditions to yield cytidine and phenyl ring. N4-p-Anisoylcytidine has been used as an intermediate in the synthesis of cytidine, which is subsequently converted to phenyl ring by reaction with benzene. This compound also has been used as an esterification agent for orthoesters.</p>

<p>2-Amino-N6-isopentenyladenosine is a nucleoside that is an activator of ribonucleotide reductase. It has antiviral properties and can be used as a therapeutic agent for HIV infection. 2-Amino-N6-isopentenyladenosine is also known to have anticancer properties, although it is not well studied.</p>